Munchen, Germany
Bruker Biosensors is a cutting-edge player in the analytical systems sector, specializing in the characterization of biomolecules and molecular interactions. Established in 2013 and headquartered in Germany, the company targets the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Their innovative solutions enable significant advancements in drug discovery, life sciences research, and cell and gene therapies.
With a focus on providing state-of-the-art instruments and consumables for the detailed analysis of biomolecular interactions on biochips and single cells, Bruker Biosensors positions itself as a pivotal contributor to future healthcare advancements.
The last financial milestone for the company was a Series A investment on 01 March 2016, led by UVC Partners. As the company continues its trajectory of innovation, it presents a compelling opportunity for investors interested in transformative healthcare technologies.
